Opportunity Information: Apply for HT9425 23 RTRP ATDA
The DOD Reconstructive Transplant, Advanced Technology Development Award (FY23 RTRP ATDA; opportunity number HT9425 23 RTRP ATDA) is a Department of Defense funding opportunity run through the U.S. Army Medical Research Acquisition Activity (USAMRAA) that supports science and technology research aimed at moving reconstructive transplantation innovations from strong preclinical results toward real-world, deployable products. The core purpose is translation: taking something that already has proof-of-concept or an early prototype and advancing it through the kind of rigorous, reproducible development work needed to set up the next step, such as clinical trials or another defined development milestone. The mechanism is offered as a cooperative agreement or grant, categorized under CFDA 12.420, and eligibility is listed as unrestricted, meaning many organization types can apply as long as they meet any additional eligibility language in the full announcement.
A major emphasis of this award is on study design and feasibility. Applicants are expected to lay out a clear, well-integrated experimental plan that is methodologically strong and built for reproducibility, with enough detail to show the work can actually be executed and will generate interpretable results. Where statistics apply, the application should include a statistical plan and appropriate power analysis, rather than treating statistics as an afterthought. Reviewers are looking for a development-ready approach, so the design should not only test a hypothesis, but also intentionally position the product to advance into its next development phase. In other words, the project should be engineered to reduce the typical risks that stall translation (uncertain feasibility, weak rigor, unclear endpoints, inconsistent methods, or insufficient planning for scale-up and next-step validation).
Military relevance and impact are also central. The research has to connect directly to the needs of military Service Members and/or Veterans recovering from traumatic injury, and it should also consider the practical needs of those who support them, including family members, caregivers, and clinicians. Applicants are expected to describe both short-term and long-term impact in a straightforward way: what the product will change, how it will improve outcomes or care delivery, and why this matters specifically in the context of traumatic injury and reconstructive transplantation. Projects must align with at least one of the program’s specified focus areas (referenced in the notice as the FY22 RTRP Advanced Technology Development Award Focus Areas). While working with military or VA researchers and clinicians is encouraged and can strengthen the practical relevance of the project, it is not presented as a strict requirement.
A required element is a transition plan, described as a post-award Transition Plan (Attachment 9). This is where applicants must show they are not stopping at a promising set of results, but actively planning for what comes next after the award ends. The transition plan should identify plausible next sources of funding and resources and explain the concrete pathway for advancing the product to the next level of development, such as preparing for clinical evaluation, meeting regulatory milestones, or moving toward delivery in military and/or civilian healthcare markets. If the product being developed has regulatory implications (for example, a device, biologic, or combination product), the application should include a regulatory strategy that demonstrates awareness of the approval or clearance environment and shows how regulatory requirements will be addressed as development continues.
The award also expects applicants to come in with meaningful preliminary data. This is not meant for brand-new, untested ideas; there should already be proof-of-concept evidence that the proposed product could be useful, or there should be a prototype or preliminary version of the product in hand. The application should include preliminary and/or published data that supports the scientific rationale and relevance to reconstructive transplantation. Those data can be unpublished if they come from the proposing team, and they can also draw on published literature, but the overall message has to be that the work is ready to be advanced rather than discovered from scratch.
Finally, the program explicitly notes that it is acceptable to leverage novel findings from solid organ transplantation research and test them in a vascularized composite allotransplantation (VCA) context, as long as the applicant clearly justifies why that translation is scientifically and clinically meaningful. The proposal should explain whether results might differ in VCA compared to solid organ settings, why confirming similarity matters, or how repeating or adapting the work for VCA could reveal new mechanisms or unique aspects of VCA biology and clinical management. This signals that the program is open to cross-pollination from related transplant fields, but only when the rationale is clear and the expected benefit to reconstructive transplantation is convincingly explained.
Key logistics included in the listing note that the opportunity was posted June 5, 2023, with an original closing date of October 11, 2023, and an expectation of approximately three awards. The award ceiling is shown as 0 in the listing, which typically means applicants need to consult the full announcement for budget limits or that the ceiling is not specified in that particular summary field. Overall, the opportunity is structured for teams that already have a credible foundation and are ready to do the hard translational work: rigorous development studies, clear relevance to military trauma recovery, and a believable plan to move the product into the next stage beyond the grant.Apply for HT9425 23 RTRP ATDA
- The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Reconstructive Transplant, Advanced Technology Development Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on Jun 05, 2023.
- Applicants must submit their applications by Oct 11, 2023. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: DOD Reconstructive Transplant, Advanced Technology Development Award (FY23 RTRP ATDA)
What is the FY23 RTRP Advanced Technology Development Award (ATDA)?
The FY23 Reconstructive Transplant, Advanced Technology Development Award (RTRP ATDA; opportunity number HT9425 23 RTRP ATDA) is a Department of Defense (DOD) funding opportunity administered through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It supports science and technology research that advances reconstructive transplantation innovations from strong preclinical results toward real-world, deployable products.
What is the main purpose of this award?
The central purpose is translation. The award is intended to take a project that already has proof-of-concept evidence or an early prototype and move it forward through rigorous, reproducible development work. The goal is to position the product for the next defined development step, such as clinical trials or another clearly identified milestone.
What stage of research is this award designed for?
This mechanism is positioned for projects that are beyond early discovery. Applicants are expected to have meaningful preliminary data and a credible foundation showing the product is ready to be advanced, not invented from scratch.
Is this award intended for brand-new, untested ideas?
No. The program expects meaningful preliminary data and/or proof-of-concept evidence. It is described as not meant for brand-new, untested ideas; the application should demonstrate readiness for development and translation.
What kinds of outcomes is the program trying to achieve?
The program aims to reduce common translation risks that can stall progress, such as uncertain feasibility, weak rigor, unclear endpoints, inconsistent methods, or insufficient planning for scale-up and next-step validation. The work should be structured to produce interpretable results that support moving into the next development phase.
What type of funding mechanism is used?
The opportunity is offered as a cooperative agreement or a grant.
What CFDA number is associated with this opportunity?
The listing identifies CFDA 12.420.
Who is eligible to apply?
Eligibility is listed as unrestricted, meaning many organization types may apply, as long as they meet any additional eligibility language included in the full announcement.
How important is study design and feasibility in the review?
Study design and feasibility are major emphases. Applicants are expected to present a clear, well-integrated experimental plan that is methodologically strong, reproducible, detailed enough to demonstrate executable work, and capable of generating interpretable results.
Are statistics and power analysis expected in the application?
Yes, where statistics apply. The opportunity notes that applications should include a statistical plan and appropriate power analysis, rather than treating statistics as an afterthought.
Does the project need to be development-ready rather than purely hypothesis-driven?
The design is expected to do more than test a hypothesis. Reviewers are looking for a development-ready approach that intentionally positions the product to advance into its next development phase.
What does the program mean by "translation" in this context?
Translation here means advancing an innovation with strong preclinical results toward a deployable product by doing rigorous development work that supports the next milestone, such as clinical evaluation readiness, another defined development gate, or similar forward movement beyond proof-of-concept.
What kind of military relevance is required?
Military relevance is central. The research must connect directly to the needs of military Service Members and/or Veterans recovering from traumatic injury, and it should also consider the practical needs of those who support them, including family members, caregivers, and clinicians.
How should applicants describe impact?
Applicants are expected to describe short-term and long-term impact in a straightforward way, including what the product will change, how it will improve outcomes or care delivery, and why that matters specifically for traumatic injury and reconstructive transplantation.
Does the project need to fit within specific program focus areas?
Yes. Projects must align with at least one of the program's specified focus areas, referenced as the FY22 RTRP Advanced Technology Development Award Focus Areas.
Is collaboration with military or VA researchers required?
Collaboration with military or VA researchers and clinicians is encouraged and may strengthen practical relevance, but it is not presented as a strict requirement in the summary provided.
Is a Transition Plan required?
Yes. A transition plan is described as a required element and is provided as a post-award Transition Plan (Attachment 9).
What is the Transition Plan expected to cover?
The Transition Plan should show a credible pathway for what comes after the award ends. It should identify plausible next sources of funding and resources and explain the concrete pathway for advancing the product to the next development level, such as preparing for clinical evaluation, meeting regulatory milestones, or moving toward delivery in military and/or civilian healthcare markets.
Is a regulatory strategy required?
If the product has regulatory implications (for example, a device, biologic, or combination product), the application should include a regulatory strategy that shows awareness of the approval or clearance environment and explains how regulatory requirements will be addressed as development continues.
What kind of preliminary data is expected?
The application is expected to include preliminary and/or published data supporting the scientific rationale and relevance to reconstructive transplantation. Data can be unpublished if generated by the proposing team, and can also draw on published literature, but should clearly indicate readiness to advance.
Can applicants build on solid organ transplantation findings for a VCA application?
Yes. The program explicitly notes it is acceptable to leverage novel findings from solid organ transplantation research and test them in a vascularized composite allotransplantation (VCA) context, as long as the applicant clearly justifies why that translation is scientifically and clinically meaningful.
What kind of justification is expected when translating solid organ findings to VCA?
The proposal should explain whether results might differ in VCA compared to solid organ settings, why confirming similarity matters, or how repeating or adapting the work for VCA could reveal new mechanisms or unique aspects of VCA biology and clinical management.
When was this opportunity posted and what was the original closing date?
The listing notes the opportunity was posted on June 5, 2023, with an original closing date of October 11, 2023.
How many awards are expected?
The listing indicates an expectation of approximately three awards.
What is the maximum award amount (ceiling)?
The listing shows an award ceiling of 0, which typically indicates applicants need to consult the full announcement for budget limits or that the ceiling is not specified in that summary field.
What does "deployable products" mean in the context of this award?
Based on the description provided, "deployable products" refers to innovations that are being advanced beyond preclinical proof-of-concept toward real-world use, with development work aimed at enabling the next step (such as clinical trials, regulatory milestones, or other defined development gates) and eventual delivery in military and/or civilian healthcare markets.
What kind of project team is this opportunity best suited for?
The opportunity is structured for teams that already have a credible scientific and technical foundation and are ready to do the rigorous translational work needed to advance toward the next stage beyond the grant, including strong study design, military relevance to traumatic injury recovery, and a believable transition pathway.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: BJA FY 23 Invited to Apply - Courts, Communities and Strategic Partnerships
Previous opportunity: DoD Combat Readiness - Translational Research Award
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT9425 23 RTRP ATDA
Applicants also applied for:
Applicants who have applied for this opportunity (HT9425 23 RTRP ATDA) also looked into and applied for these:
| Funding Opportunity |
|---|
| Natural and Cultural Resources Support for Joint Base Langley Eustis, Joint Base Andrews and Joint Base Anacostia Bolling, Virginia/Washington D.C. Apply for W9126G 23 2 SOI 3325 Funding Number: W9126G 23 2 SOI 3325 Agency: Department of Defense Category: Science and Technology and other Research and Development Funding Amount: $2,828,460 |
| DoD Kidney Cancer, Translational Research Partnership Award Apply for HT9425 23 KCRP TRPA Funding Number: HT9425 23 KCRP TRPA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Scholar Award Apply for HT9425 23 KCRP AKCIECSA Funding Number: HT9425 23 KCRP AKCIECSA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Kidney Cancer, Nurse Initiated Research Award Apply for HT9425 23 KCRP NIRA Funding Number: HT9425 23 KCRP NIRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Kidney Cancer, Clinical Trial Award Apply for HT9425 23 KCRP CTA Funding Number: HT9425 23 KCRP CTA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Kidney Cancer, Idea Development Award Apply for HT9425 23 KCRP IDA Funding Number: HT9425 23 KCRP IDA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development Apply for 2023 NIST RAMPS 01 Funding Number: 2023 NIST RAMPS 01 Agency: Department of Commerce, National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Wildland Fire Management Planning for Redstone Arsenal Apply for W9126G 22 2 SOI 3385 Funding Number: W9126G 22 2 SOI 3385 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $90,358 |
| DoD Pancreatic Cancer Focused Pilot Award Apply for HT9425 23 PCARP FPTA Funding Number: HT9425 23 PCARP FPTA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Duchenne Muscular Dystrophy Translational Research Award Apply for HT9425 23 DMDRP TRA Funding Number: HT9425 23 DMDRP TRA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Duchenne Muscular Dystrophy Idea Development Award Apply for HT9425 23 DMDRP IDA Funding Number: HT9425 23 DMDRP IDA Agency: Department of Defense, Dept. of the Army -- USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Economic Valuation of Freshwater Lakes and Reservoirs Experiencing Harmful Algal Blooms Apply for W81EWF 23 SOI 0019 Funding Number: W81EWF 23 SOI 0019 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $300,000 |
| Historically Black Colleges and Universities - Excellence in Research Apply for 23 598 Funding Number: 23 598 Agency: National Science Foundation Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Wildland Fire Management Planning for Redstone Arsenal Apply for W9126G 23 2 SOL 3385 Funding Number: W9126G 23 2 SOL 3385 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $90,358 |
| Wildland Fire Management Planning for Redstone Arsenal Apply for W9126G 23 2 SOI 3385 Funding Number: W9126G 23 2 SOI 3385 Agency: Department of Defense, Fort Worth District Category: Science and Technology and other Research and Development Funding Amount: $90,358 |
| Dendrochronological Investigations to Evaluate Forest Ecosystems Apply for W81EWF 23 SOI 0020 Funding Number: W81EWF 23 SOI 0020 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $50,000 |
| Civil Works Research and Development (R&D) Collider Apply for W912HZ23BAA02 Funding Number: W912HZ23BAA02 Agency: Department of Defense, Dept. of the Army -- Corps of Engineers Category: Science and Technology and other Research and Development Funding Amount: $20,000,000 |
| "Researching Impacts and Data Gaps Associated with Harmful Algal Blooms in Freshwater Lakes and Reservoirs" Apply for W81EWF 23 SOI 0018 Funding Number: W81EWF 23 SOI 0018 Agency: Department of Defense, Dept. of the Army -- Corps of Engineers Category: Science and Technology and other Research and Development Funding Amount: $300,000 |
| Evaluation of microbially induced calcite precipitation (MICP) and vegetation interaction for soil rehabilitation Apply for W81EWF 23 SOI 0023 Funding Number: W81EWF 23 SOI 0023 Agency: Department of Defense, Engineer Research and Development Center Category: Science and Technology and other Research and Development Funding Amount: $85,000 |
| “Overland Assessment of Physical Environments for Mobility in Complex Ecological Landscapes” Apply for W81EWF 23 SOI 0022 Funding Number: W81EWF 23 SOI 0022 Agency: Department of Defense, Dept. of the Army -- Corps of Engineers Category: Science and Technology and other Research and Development Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT9425 23 RTRP ATDA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.